Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines

Questions and concerns regarding the efficacy and immunogenicity of coronavirus disease 2019 (COVID-19) vaccines have plagued scientists since the BNT162b2 mRNA vaccine was introduced in late 2020. As a result, decisions about vaccine boosters based on breakthrough infection rates and the decline of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepand, Mohammad Reza, Bigdelou, Banafsheh, Ho, Jim Q., Sharaf, Mohammad, Lannigan, Alexis J., Sullivan, Ian M., da Silva, Alecsander P., Barrett, Leland O., McGoldrick, Scott, Lnu, Yuvraj, Lynch, Shannon E., Boisclair, Jared M., Barnard-Pratt, Dakarai D., Zanganeh, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149948/
https://www.ncbi.nlm.nih.gov/pubmed/35645208
http://dx.doi.org/10.3390/antib11020035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149948/
https://www.ncbi.nlm.nih.gov/pubmed/35645208
http://dx.doi.org/10.3390/antib11020035

Ejemplares similares